Roivant Sciences Ltd. ROIV
8 insiders sold $304.4M on the market, none bought
Form 4Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.
A year of insider trades, day by day
Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025
$0 bought on 0 days, $304.4M sold on 23 days. Each square is a day; click one for its Form 4.
Buys and sales by insider
Who traded · Form 4, added up
| Insider | Bought | Sold | Latest |
|---|---|---|---|
| Mayukh Sukhatme President & CIO, Director |
- | $70.6M | Aug 21, 2026 |
| Eric Venker President & Immunovant CEO |
- | $63.4M | Nov 10, 2026 |
| Keith S. Manchester Director |
- | $56.4M | Jun 30, 2026 |
| QVT Financial LP | - | $49.4M | Jun 30, 2026 |
| Daniel Allen Gold Director |
- | $49.4M | Jun 30, 2026 |
| Richard Pulik CFO |
- | $12.5M | Nov 11, 2026 |
| Melissa B. Epperly Director |
- | $1.4M | Oct 1, 2026 |
| Meghan Fitzgerald Director |
- | $1.4M | Sep 15, 2026 |
Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.
Trade by trade, newest first
Every trade · each date links to its Form 4
Of 52 open-market sales by officers and directors, 5 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 11, 2026 | Richard Pulik | Sale | -45,195 | 1.9M |
| Nov 11, 2026 | Richard Pulik | Sale | -82,170 | 3.5M |
| Nov 11, 2026 | Richard Pulik | Sale | -47,635 | 2.0M |
| Nov 10, 2026 | Eric Venker | Sale (10b5-1) | -158,194 | 6.4M |
| Nov 10, 2026 | Eric Venker | Sale (10b5-1) | -29,749 | 1.2M |
| Nov 10, 2026 | Richard Pulik | Sale | -125,000 | 5.2M |
| Nov 3, 2026 | Eric Venker | Sale (10b5-1) | -200,000 | 7.3M |
| Oct 28, 2026 | Eric Venker | Sale (10b5-1) | -200,000 | 7.3M |
| Oct 20, 2026 | Eric Venker | Sale (10b5-1) | -185,856 | 6.5M |
| Oct 20, 2026 | Eric Venker | Sale (10b5-1) | -14,144 | 501K |
| Oct 1, 2026 | Melissa B. Epperly | Sale (10b5-1) | -16,850 | 608K |
| Oct 1, 2026 | Melissa B. Epperly | Sale (10b5-1) | -900 | 33K |
| Sep 30, 2026 | Eric Venker | Sale (10b5-1) | -200,000 | 7.3M |
| Sep 15, 2026 | Meghan Fitzgerald | Sale (10b5-1) | -4,712 | 187K |
| Sep 15, 2026 | Meghan Fitzgerald | Sale (10b5-1) | -400 | 16K |
| Sep 15, 2026 | Melissa B. Epperly | Sale (10b5-1) | -4,338 | 172K |
| Sep 15, 2026 | Melissa B. Epperly | Sale (10b5-1) | -600 | 24K |
| Sep 8, 2026 | Meghan Fitzgerald | Sale (10b5-1) | -20,000 | 798K |
| Aug 28, 2026 | Eric Venker | Sale (10b5-1) | -166,182 | 5.9M |
| Aug 28, 2026 | Eric Venker | Sale (10b5-1) | -33,818 | 1.2M |
| Aug 21, 2026 | Mayukh Sukhatme | Sale | -144,756 | 5.3M |
| Aug 20, 2026 | Mayukh Sukhatme | Sale | -17,519 | 653K |
| Aug 19, 2026 | Mayukh Sukhatme | Sale | -172,899 | 6.4M |
| Aug 18, 2026 | Mayukh Sukhatme | Sale | -105,141 | 3.8M |
| Aug 18, 2026 | Mayukh Sukhatme | Sale | -31,801 | 1.2M |
| Aug 17, 2026 | Mayukh Sukhatme | Sale | -284,707 | 10.3M |
| Aug 14, 2026 | Mayukh Sukhatme | Sale | -243,177 | 8.8M |
| Jul 27, 2026 | Eric Venker | Sale (10b5-1) | -200,000 | 7.0M |
| Jun 30, 2026 | QVT Financial LP (indirect) | Sale | -12,380 | 437K |
| Jun 30, 2026 | Daniel Allen Gold (indirect) | Sale | -12,380 | 437K |
| Jun 30, 2026 | Keith S. Manchester (indirect) | Sale | -12,380 | 437K |
| Jun 30, 2026 | Keith S. Manchester | Sale | -200,000 | 7.1M |
| Jun 30, 2026 | Meghan Fitzgerald | Sale (10b5-1) | -10,000 | 349K |
| Jun 29, 2026 | QVT Financial LP (indirect) | Sale | -200,000 | 6.9M |
| Jun 29, 2026 | QVT Financial LP (indirect) | Sale | -600,000 | 20.8M |
| Jun 29, 2026 | Daniel Allen Gold (indirect) | Sale | -200,000 | 6.9M |
| Jun 29, 2026 | Daniel Allen Gold (indirect) | Sale | -600,000 | 20.8M |
| Jun 29, 2026 | Keith S. Manchester (indirect) | Sale | -200,000 | 6.9M |
| Jun 29, 2026 | Keith S. Manchester (indirect) | Sale | -600,000 | 20.8M |
| Jun 29, 2026 | Melissa B. Epperly | Sale (10b5-1) | -15,002 | 515K |
| Jun 29, 2026 | Melissa B. Epperly | Sale (10b5-1) | -2,748 | 95K |
| Jun 26, 2026 | QVT Financial LP (indirect) | Sale | -300,783 | 10.2M |
| Jun 26, 2026 | QVT Financial LP (indirect) | Sale | -325,000 | 11.1M |
| Jun 26, 2026 | Daniel Allen Gold (indirect) | Sale | -300,783 | 10.2M |
| Jun 26, 2026 | Daniel Allen Gold (indirect) | Sale | -325,000 | 11.1M |
| Jun 26, 2026 | Keith S. Manchester (indirect) | Sale | -300,783 | 10.2M |
| Jun 26, 2026 | Keith S. Manchester (indirect) | Sale | -325,000 | 11.1M |
| Jun 26, 2026 | Mayukh Sukhatme | Sale | -500,000 | 17.0M |
| Jun 25, 2026 | Mayukh Sukhatme | Sale | -500,000 | 17.1M |
| Jun 24, 2026 | Eric Venker | Sale (10b5-1) | -153,766 | 5.1M |
| Jun 24, 2026 | Eric Venker | Sale (10b5-1) | -46,234 | 1.5M |
| May 22, 2026 | Eric Venker | Sale (10b5-1) | -200,000 | 6.1M |
Show the other 37 trades
Sources
Form 4s from SEC's filing index. An insider files one within two business days of a trade.
Also
Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ROIV/export.csv") into a cell.